SEC Tracker
Get the app

Bioforce Nanosciences Holdings BFNH

Bioforce Nanosciences Holdings Q1 FY26: net loss $102K; diluted EPS $0.00

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Bioforce Nanosciences Holdings reported for Q1 FY26, the quarter ended Mar 31, 2026, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income−$102KAgainst −$935K in Q1 FY2510-Q income statement, on EDGAR
  2. Diluted EPS$0.00Against −$0.03 in Q1 FY2510-Q income statement, on EDGAR
  3. Cash and cash equivalents$6K−54% from $14K in Q1 FY2510-Q balance sheet, on EDGAR
  4. Cash from operations$7KAgainst −$15K in Q1 FY2510-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Bioforce Nanosciences Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3826 and related industry codes: the same peer list as the financial tables.

  1. Scientific Industries SCND public float $4M, Jun 30, 2025
  2. Lifeloc Technologies LCTC public float $2M, Jun 30, 2025
  3. US Nuclear UCLE public float $1M, Jun 30, 2025
  4. ASTROTECH ASTC public float $5M, Dec 31, 2025
  5. Electro Sensors ELSE public float $6M, Jun 30, 2025